Continuous Glucose Monitoring (CGM) Market Trends & Summary
Market Overview
The global Continuous Glucose Monitoring (CGM) Market is expected to witness substantial growth. Estimated at approximately US$ 6.82 billion in 2024, it is projected to reach US$ 14.1 billion by 2033, reflecting a strong CAGR of 8.41% from 2024 to 2033. This expansion is primarily driven by the rising prevalence of diabetes, technological advancements in glucose monitoring, and an increasing focus on effective diabetes management worldwide.
Free Download Sample Report: https://www.renub.com/request-sample-page.php?gturl=global-cgm-market-users-reimbursement-policy-continuous-glucose-monitoring-p.php
CGM Market Report Insights
Report Scope
- Component Segmentation: Sensors, Transmitters, Receivers
- End-User Segmentation: Hospitals, Homecare Settings, Others
- Geographic Coverage: Global analysis, including key regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa
- Company Analysis: Key industry players, recent developments, and revenue trends
Key Market Statistics
| Feature | Details |
| Base Year | 2024 |
| Forecast Period | 2025 – 2033 |
| Historical Data | 2020 – 2024 |
| Market Size (2024) | US$ 6.82 Billion |
| Market Forecast (2033) | US$ 14.1 Billion |
| CAGR (2025-2033) | 8.41% |
Continuous Glucose Monitoring Market Outlook
Continuous Glucose Monitoring (CGM) is a transformative healthcare technology that continuously tracks blood glucose levels throughout the day and night. Unlike traditional finger-stick methods, CGM devices use a subcutaneous sensor to measure glucose levels in interstitial fluid, transmitting data to a display device or smartphone for real-time monitoring.
CGM Benefits:
- Improved diabetes management: Provides insights into glucose trends, helping patients adjust lifestyle choices such as diet and exercise.
- Alerts for high/low glucose levels: Enables timely interventions, reducing risks of complications.
- Enhanced hospital applications: Increasingly used in intensive care units and for monitoring critically ill patients.
Growth Drivers in the CGM Market
Increasing Diabetes Prevalence
The global rise in diabetes cases is a key market driver. An estimated 537 million adults (20-79 years old) had diabetes in 2022, a number projected to rise to 643 million by 2030 and 783 million by 2045. The shift toward early diagnosis and preventive healthcare further fuels CGM adoption.
Technological Advancements
- Improved sensor accuracy and extended lifespan
- Smartphone and insulin pump integration
- Wearable CGM devices with predictive analytics
For instance, in August 2024, Abbott and Medtronic announced a CGM system integrating FreeStyle Libre technology with Medtronic’s insulin systems, enhancing automated diabetes management.
Growth of Homecare Solutions
- CGM devices reduce hospital visits, offering cost-effective, remote glucose monitoring.
- Remote patient monitoring enables healthcare providers to track glucose levels, improving patient care.
- High demand among pediatric and geriatric patients for convenient diabetes management.
Challenges in the CGM Market
High Costs of CGM Devices
- Upfront costs and recurring expenses for sensors/accessories limit adoption in low- and middle-income countries.
- Limited insurance coverage reduces accessibility.
Accuracy & Calibration Issues
- Discrepancies in glucose readings may affect reliability.
- Regular calibration is required for optimal performance.
- Addressing these technical challenges is crucial for wider adoption and market growth.
Segment Analysis
CGM Sensors Market
Sensors are the core components of CGM systems, continuously tracking glucose levels. Advancements in sensor technology are improving accuracy, longevity, and ease of use. Industry investments focus on affordable, long-lasting sensors to enhance patient accessibility.
CGM Receivers Market
Receivers display real-time glucose data and trends. Integration with smartphones and cloud platforms has enhanced patient engagement. The demand for advanced data-sharing features is increasing adoption among healthcare providers and patients.
CGM Market in Hospitals
Hospitals increasingly adopt CGM technology for real-time glucose monitoring of critically ill patients. CGM devices in ICUs and surgical settings improve patient outcomes by preventing glucose fluctuations. The hospital segment is expected to expand significantly.
CGM Market in Homecare Settings
Home-based CGM solutions are a major growth driver, driven by:
- The aging population
- Increasing preference for home monitoring
- Enhanced telehealth integration for remote diabetes management
Regional Insights
United States CGM Market
- Largest market share due to high diabetes prevalence (98 million adults with prediabetes).
- Strong healthcare infrastructure and insurance coverage encourage adoption.
- Government support for digital health technologies accelerates CGM market growth.
Germany CGM Market
- Growing diabetes cases and advanced healthcare solutions boost market expansion.
- Public & private insurance coverage enhances accessibility.
- January 2023: LifeScan published a real-world diabetes study involving 144,000+ patients, highlighting CGM benefits.
India CGM Market
- Rapid market growth due to rising diabetes cases.
- Cost barriers remain, but innovations in low-cost CGM systems improve accessibility.
- February 2023: Dario Health partnered with Dexcom to integrate CGM data with its chronic disease management platform.
Brazil CGM Market
- Expanding market fueled by government healthcare investments.
- October 2023: Molex and GlucoModicum launched a needle-free CGM device, enhancing patient comfort.
UAE CGM Market
- Market growth driven by preventive healthcare initiatives and government support for digital health technologies.
- October 2023: PureHealth’s AI-powered health app “Pura” saw over 140,000 downloads, reflecting rising adoption of health tech solutions.
Market Segmentation
By Component
- Sensors
- Transmitters
- Receivers
By End-User
- Hospitals
- Homecare Settings
- Others
By Region
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Turkey
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
The CGM market is dominated by leading players engaged in innovation, partnerships, and product development.
Key Players Analysis
| Company | Key Highlights |
| Abbott Laboratories | FreeStyle Libre technology, partnerships with Medtronic |
| Roche | Focus on diabetes management solutions |
| Tandem Diabetes Care | Innovative insulin pump-CGM integrations |
| DexCom Inc. | Cutting-edge CGM technology and mobile integration |
| Senseonics Holdings Inc. | Implantable CGM sensors for long-term monitoring |
| Ypsomed Holding AG | Expansion in insulin delivery and CGM solutions |
| Medtronic Plc. | AI-driven diabetes management tools |
| i-Sens Inc. | Affordable CGM solutions targeting emerging markets |
Conclusion
The Continuous Glucose Monitoring Market is set for significant expansion, driven by technological advancements, increasing diabetes prevalence, and the growing demand for home-based healthcare solutions. While high costs and accuracy issues remain challenges, ongoing innovations and strategic collaborations will continue to propel market growth in the coming years.
About Us
Renub Research is a leading market research and advisory firm with over 15 years of experience in providing business-to-business global market research, business surveys, and management consulting. Our firm is dedicated to offering a comprehensive suite of services tailored to help businesses make informed decisions.
We partner with our clients to identify their greatest opportunities, address pressing issues, and navigate the changes required to drive success. Our clients span across various high-stakes industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecoms & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.
Our Expertise
Renub Research is trusted by top global organizations for our deep insights, actionable market information, and precise market data that empower our clients to make well-informed decisions. We are a well-established provider of industry solutions, and our research is pivotal in assisting consultants, bankers, and executives with crafting solid business strategies.
Our team consists of highly skilled professionals with expertise in finance, marketing, human resources, biotechnology, pharmaceuticals, IT, environmental science, and other related fields. The studies we conduct form the foundation of management decisions, including strategies, organizational structures, activities, technology use, and merger and acquisition opportunities.
Why Choose Renub Research?
- Comprehensive Market Insights: Our reports provide detailed information and insights on opportunities and trends across various industries.
- Strategic Analysis: We deliver in-depth analysis, helping companies understand market dynamics and competitive positioning.
- Accurate Forecasting: Our forecast and estimation methodologies ensure that managers have reliable data to make decisions in a rapidly changing global economy.
With a solid reputation for delivering impactful research, Renub Research is proud to support a number of global players by providing not only IT solutions but also comprehensive overviews of market opportunities. Our research empowers companies to stay ahead in the competitive global landscape.
